Den Mark Pharmaceuticals

Den Mark Pharmaceuticals is an Indian pharmaceutical manufacturer and exporter headquartered in Mumbai, with a state-of-the-art manufacturing plant in Roorkee, Uttarakhand. The company specializes in producing high-quality finished dosage formulations, including tablets, capsules, syrups, and ointments, with a significant emphasis on cephalosporins and beta-lactams. As a WHO-GMP and ISO certified entity, Den Mark operates a robust third-party contract manufacturing (CDMO) business and exports its products to over a dozen global markets across Africa, Southeast Asia, and the Middle East. Under the leadership of CEO Samad Hussain Patanwala, the firm leverages advanced infrastructure and research to address critical healthcare needs in areas such as oncology and infectious diseases. The company’s manufacturing operations encompass over 66,000 square feet and are designed to meet stringent EU-GMP standards for both domestic and international supply.